loadpatents
name:-0.038957834243774
name:-0.03347110748291
name:-0.0068449974060059
ZACHARIE; Boulos Patent Filings

ZACHARIE; Boulos

Patent Applications and Registrations

Patent applications and USPTO patent grants for ZACHARIE; Boulos.The latest application filed is for "substituted aromatic compounds and pharmaceutical uses thereof".

Company Profile
4.30.27
  • ZACHARIE; Boulos - Laval CA
  • Zacharie; Boulos - Quebec CA
  • Zacharie; Boulos - Laval des Rapides CA
  • Zacharie, Boulos - Laval del Rapides CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted Aromatic Compounds and Pharmaceutical Uses Thereof
App 20210002202 - ZACHARIE; Boulos ;   et al.
2021-01-07
Substituted aromatic compounds and pharmaceutical uses thereof
Grant 10,815,183 - Zacharie , et al. October 27, 2
2020-10-27
Substituted Aromatic Compounds And Related Method For The Treatment Of Fibrosis
App 20200172462 - ZACHARIE; Boulos ;   et al.
2020-06-04
Substituted aromatic compounds and related method for the treatment of fibrosis
Grant 10,550,066 - Zacharie , et al. Fe
2020-02-04
Substituted Aromatic Compounds and Related Method for the Treatment of Fibrosis
App 20180237374 - ZACHARIE; Boulos ;   et al.
2018-08-23
Substituted aromatic compounds and related method for the treatment of fibrosis
Grant 10,023,518 - Zacharie , et al. July 17, 2
2018-07-17
Substituted Aromatic Compounds And Pharmaceutical Uses Thereof
App 20180162799 - ZACHARIE; Boulos ;   et al.
2018-06-14
Substituted aromatic compounds and pharmaceutical uses thereof
Grant 9,938,221 - Zacharie , et al. April 10, 2
2018-04-10
Substituted aromatic compounds for the treatment pulmonary fibrosis, liver fibrosis, skin fibrosis and cardiac fibrosis
Grant 9,884,802 - Gagnon , et al. February 6, 2
2018-02-06
Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
Grant 9,682,054 - Penney , et al. June 20, 2
2017-06-20
Phenylketone carboxylate compounds and pharmaceutical uses thereof
Grant 9,475,750 - Zacharie , et al. October 25, 2
2016-10-25
Compounds and compositions for the treatment of cancer
Grant 9,439,882 - Gagnon , et al. September 13, 2
2016-09-13
Substituted Aromatic Compounds and Related Method for the Treatment of Fibrosis
App 20160039736 - ZACHARIE; Boulos ;   et al.
2016-02-11
Substituted Aromatic Compounds For The Treatment Of Pulmonary Fibrosis, Liver Fibrosis,skin Fibrosis And Cardiac Fibrosis
App 20160023983 - GAGNON; Lyne ;   et al.
2016-01-28
Compounds And Compositions For The Treatment Of Cancer
App 20150313856 - GAGNON; Lyne ;   et al.
2015-11-05
Compounds and compositions for the treatment of cancer
Grant 9,114,118 - Gagnon , et al. August 25, 2
2015-08-25
Substituted Aromatic Compounds And Pharmaceutical Uses Thereof
App 20150094372 - ZACHARIE; Boulos ;   et al.
2015-04-02
Substituted aromatic compounds and pharmaceutical uses thereof
Grant 8,927,765 - Zacharie , et al. January 6, 2
2015-01-06
Salts of 3-pentylphenylacetic acid and pharmaceutical uses thereof
Grant 8,637,574 - Zacharie , et al. January 28, 2
2014-01-28
Phenylketone Carboxylate Compounds and Pharmaceutical Uses Thereof
App 20130225681 - Zacharie; Boulos ;   et al.
2013-08-29
Compounds and Compositions for the Treatment of Cancer
App 20130217645 - Gagnon; Lyne ;   et al.
2013-08-22
Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
Grant 8,487,001 - Gagnon , et al. July 16, 2
2013-07-16
Triazine derivatives, compositions containing such derivatives, and methods of treatment of cancer and autoimmune diseases using such derivatives
Grant 8,258,295 - Zacharie , et al. September 4, 2
2012-09-04
Salts of 3-Pentylphenylacetic Acid and Pharmaceutical Uses Thereof
App 20120095102 - Zacharie; Boulos ;   et al.
2012-04-19
Substituted Aromatic Compounds and Pharmaceutical Uses thereof
App 20120088784 - Zacharie; Boulos ;   et al.
2012-04-12
Purine derivatives and their use for treatment of autoimmune diseases
Grant 8,080,555 - Zacharie , et al. December 20, 2
2011-12-20
Medium-Chain Length Fatty Acids, Glycerides and Analogues as Neutrophil Survival and Activation Factors
App 20100279959 - Gagnon; Lyne ;   et al.
2010-11-04
Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
Grant 7,745,488 - Gagnon , et al. June 29, 2
2010-06-29
Triazine Derivatives, Compositions Containing Such Derivatives, and Methods of Treatment of Cancer and Autoimmune Diseases Using Such Derivatives
App 20100129350 - Zacharie; Boulos ;   et al.
2010-05-27
Preparation of metal salts of medium-chain fatty acids
Grant 7,705,169 - Duceppe , et al. April 27, 2
2010-04-27
Triazine dimers for the treatment of autoimmune diseases
Grant 7,683,061 - Penney , et al. March 23, 2
2010-03-23
Triazine compounds and compositions thereof for the treatment of cancers
App 20090075867 - Gagnon; Lyne ;   et al.
2009-03-19
2,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their use
App 20090068169 - Penney; Christopher ;   et al.
2009-03-12
Purine derivatives and their use for treatment of autoimmune diseases
App 20090042768 - Zacharie; Boulos ;   et al.
2009-02-12
Substituted Purinyl Derivatives With Immunomodulator And Chemoprotective Activity And Use Alone Or With Medium-Chain Length Fatty Acids Or Glycerides
App 20080090848 - Penney; Christopher ;   et al.
2008-04-17
Triazine dimers for the treatment of autoimmune diseases
App 20070149528 - Penney; Christopher ;   et al.
2007-06-28
Preparation of metal salts of medium-chain fatty acids
App 20070027343 - Duceppe; Jean-Simon ;   et al.
2007-02-01
Medium-chain length fatty acids, glycerides and analogues as stimulators of erythropoiesis
App 20060128800 - Penney; Christopher ;   et al.
2006-06-15
Dioxolane analogs for improved inter-cellular delivery
App 20050256034 - Attardo, Giorgio ;   et al.
2005-11-17
Processes for preparing substituted 1, 3-oxathiolanes with antiviral properties
Grant 6,831,174 - Belleau , et al. December 14, 2
2004-12-14
Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
App 20040147599 - Gagnon, Lyne ;   et al.
2004-07-29
Quinolizinones as integrin inhibitors
Grant 6,630,488 - Lamothe , et al. October 7, 2
2003-10-07
Dioxolane analogs for improved inter-cellular delivery
App 20030013660 - Attardo, Giorgio ;   et al.
2003-01-16
Processes for preparing substituted 1, 3-oxathiolanes with antiviral properties
App 20010041797 - Belleau, Bernard ;   et al.
2001-11-15
Thiophene integrin inhibitors
Grant 6,274,620 - Labrecque , et al. August 14, 2
2001-08-14
Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
Grant 6,175,008 - Belleau , et al. January 16, 2
2001-01-16
Substituted purinyl derivatives with immunomodulating activity
Grant 5,994,361 - Penney , et al. November 30, 1
1999-11-30
Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
Grant 5,684,164 - Belleau, deceased , et al. November 4, 1
1997-11-04
Processes for preparing substituted 1,3-oxathiolanes with antiviral properties
Grant 5,466,806 - Belleau, deceased , et al. November 14, 1
1995-11-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed